AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
On 27 Aug 2010, the European Commission (EC) announced decision number C(2010)5967 of 25 Aug 2010, the approval of EU orphan drug designation EU/3/10/769. The active ingredient is 11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1 (2,6).1(8,12)] heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene …